Aldosterone Antagonist Dosing and the Risk of Hyponatremia in Patients With Cirrhosis and Ascites
Main Authors: | A.S. Vogel, M. Li, S.D. Zucker |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-01-01
|
Series: | Gastro Hep Advances |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772572322001121 |
Similar Items
-
Management of Ascites in Patients with Cirrhosis: An Update
by: Giacomo Zaccherini, et al.
Published: (2021-11-01) -
Clinical Significance and Management of Hyponatremia in Liver Cirrhosis
by: Martin Janičko, et al.
Published: (2023-10-01) -
Hyponatremia – unfavourable prognostic factor in hepatic cirrhosis
by: Enescu Aurelia, et al.
Published: (2016-12-01) -
Innovative approaches to the management of ascites in cirrhosis
by: Florence Wong
Published: (2023-07-01) -
Extracorporal modified ascitic fluid reinfusion in treatment of resistant ascites in liver cirrhosis
by: I. E. Onnintsev, et al.
Published: (2017-06-01)